Cargando…

Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads

Because of the current COVID-19-pandemic, the world is currently being held hostage in various lockdowns. ACE2 facilitates SARS-CoV-2 cell-entry, and is at the very center of several pathophysiological pathways regarding the RAAS, CS, KKS, T2DM, and IL-6. Their interactions with severe COVID-19 comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoevenaar, Martijn, Goossens, Dolf, Roorda, Janne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	COVID-19 and the Renin-Angiotensin-Aldosterone System
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724427/ https://www.ncbi.nlm.nih.gov/pubmed/33283602 http://dx.doi.org/10.1177/1470320320979097

Ejemplares similares

The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients
por: Harky, Amer, et al.
Publicado: (2021)

Could angiotensin-converting enzyme 1 I/D polymorphism be a modificator of COVID-19 response in different populations, diseases, and/or conditions?
por: Dević Pavlić, Sanja, et al.
Publicado: (2020)

The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?
por: Sever, Peter, et al.
Publicado: (2020)

In vitro analysis of the renin–angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus
por: Turk, Can, et al.
Publicado: (2020)

Angiotensin II, III, and IV may be important in the progression of COVID-19
por: Cure, Erkan, et al.
Publicado: (2020)

Cardiovascular disease, heart failure and COVID-19
por: Faconti, Luca, et al.
Publicado: (2020)

Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension
por: Cure, Erkan, et al.
Publicado: (2020)

Countermeasure and therapeutic: A(1–7) to treat acute respiratory distress syndrome due to COVID-19 infection
por: Soto, Maira, et al.
Publicado: (2020)

COVID-19 and the pulmonary vascular injury
por: Dai, Hai-Long, et al.
Publicado: (2020)

COVID-19 and hypertension
por: Kulkarni, Spoorthy, et al.
Publicado: (2020)

Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression
por: Pranata, Raymond, et al.
Publicado: (2020)

COVID-19: The race for a vaccine
por: Lockey, Emily
Publicado: (2020)

Effects of ACEI and ARB on COVID-19 patients: A meta-analysis
por: Xue, Yang, et al.
Publicado: (2020)

Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation
por: Bekassy, Zivile, et al.
Publicado: (2021)

Serum aldosterone effect on left ventricular structure and diastolic function in essential hypertension
por: Al‐Hashedi, Ekhlas Mahmoud, et al.
Publicado: (2022)

STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS
por: Manoharan, Sivananthan, et al.
Publicado: (2017)

The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection
por: Carvalho, Patricia Ribeiro de, et al.
Publicado: (2021)

The kallikrein-kinin system in diabetic nephropathy
por: Tomita, Hirofumi, et al.
Publicado: (2012)

Kallikrein–kinin system: is it the fountain of youth?
por: Garaffa, Giulio, et al.
Publicado: (2017)

The Effect of the Angiotensin-Converting Enzyme Inhibitor on Bone Health in Castrated Hypertensive Rats Is Mediated via the Kinin-Kallikrein System
por: Zhang, Na, et al.
Publicado: (2022)

Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation
por: Lopatko Fagerström, Ingrid, et al.
Publicado: (2019)

Angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin‐converting enzyme 2 in patients with cardiovascular disease
por: Lebek, Simon, et al.
Publicado: (2020)

A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin–Angiotensin Systems
por: Schmaier, Alvin H.
Publicado: (2016)

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Komiyama, Maki, et al.
Publicado: (2020)

Role of the kallikrein–kinin system in traumatic brain injury
por: Albert-Weissenberger, Christiane, et al.
Publicado: (2014)

Lack of Plasma Kallikrein-Kinin System Cascade in Teleosts
por: Wong, Marty Kwok-Shing, et al.
Publicado: (2013)

Editorial: Kallikrein-kinin system: insights into a multifunctional system
por: Motta, Guacyara, et al.
Publicado: (2023)

The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study
por: Butler-Laporte, Guillaume, et al.
Publicado: (2020)

Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital trust
por: Bean, Daniel M., et al.
Publicado: (2020)

Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study
por: Kim, Ju Hwan, et al.
Publicado: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Coto, Eliecer, et al.
Publicado: (2021)

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
por: Urwyler, Pascal, et al.
Publicado: (2020)

Angiotensin converting enzyme and sodium glucose cotransporter inhibitors alleviate inflammatory effects of SARS-CoV-2 in cardiomyocytes
por: Wong, Chun-Ka, et al.
Publicado: (2022)

Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
por: Cooper, Samantha L., et al.
Publicado: (2021)

Interaction of Bacteroides fragilis and Bacteroides thetaiotaomicron with the kallikrein–kinin system
por: Murphy, Elizabeth C., et al.
Publicado: (2011)

Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity
por: Alfaro, Enrique, et al.
Publicado: (2022)

In vitro reconstitution of kallikrein-kinin system and progress curve analysis
por: Favier, Bertrand, et al.
Publicado: (2022)

An Interaction of Renin-Angiotensin and Kallikrein-Kinin Systems Contributes to Vascular Hypertrophy in Angiotensin II-Induced Hypertension: In Vivo and In Vitro Studies
por: Ceravolo, Graziela S., et al.
Publicado: (2014)

Adrenocorticotropic hormone application lowered aldosterone/cortisol value on dominant side without superior surgical outcomes during adrenal venous sampling
por: Lin, Lede, et al.
Publicado: (2023)

Surgery based on computed tomography images might be feasible for primary aldosteronism patients with visible unilateral adenoma
por: Fang, Chen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5map6jvtnaeej09333sdioj2so